The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort

Author： Duskin-Bitan Hadar   Cohen Eytan   Goldberg Elad   Shochat Tzippy   Levi Amos   Garty Moshe   Krause Ilan  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.33, Iss.4, 2014-04, pp. : 549-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A meta-analysis of alcohol consumption and the risk of gout

By Wang Meiyun   Jiang Xiubo   Wu Wenlong   Zhang Dongfeng  

Clinical Rheumatology, Vol. 32, Iss. 11, 2013-11 ,pp. : 1641-1648

Springer Publishing Company

Access to resources Recommend Favorite

Febuxostat, a novel drug for the treatment of hyperuricemia of gout

By Perez-Ruiz Fernando   Dalbeth Nicola   Schlesinger Naomi  

Future Rheumatology, Vol. 3, Iss. 5, 2008-10 ,pp. : 421-427

Future Medicine

Access to resources Recommend Favorite

Febuxostat: a safe and effective therapy for hyperuricemia and gout

By Jordan Natasha   McCarthy Geraldine M  

Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. : 303-309

Future Medicine

Access to resources Recommend Favorite

Migraine and Risk of Dementia: A Nationwide Retrospective Cohort Study

By  

Neuroepidemiology, Vol. 41, Iss. 3-4, 2013-07 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait

By  

Neuroepidemiology, Vol. 46, Iss. 3, 2016-02 ,pp. : 203-208

Karger

Access to resources Recommend Favorite